Watch an HIV expert panel discuss managing HCV infection in MSM, prescribing HIV PrEP to a PWID, and managing CVD in an HIV-infected woman.
What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide?
In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater’s role at the intersection of HIV infection, HCV infection, and the opioid crisis.
In this downloadable slideset, Daniel R. Kuritzkes, MD, and Program Directors Joseph J. Eron, Jr., MD, and Princy N. Kumar, MD, review key HIV data presented at the CROI 2018 meeting.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.